Introducing Alendronate with Cholecalciferol Tablets by PharmAlliance International Labs: A Comprehensive Approach to Bone Health

Welcome to PharmAlliance International Labs, where we are dedicated to revolutionizing healthcare with innovative solutions designed to enhance the lives of our patients. Our Alendronate with Cholecalciferol Tablets exemplify our commitment to bone health, offering a unique combination of alendronate and cholecalciferol (vitamin D3) to optimize bone strength and density.

Drug Classification:

Alendronate, a key component of our tablets, belongs to the bisphosphonate class of medications renowned for their efficacy in preventing bone loss. Cholecalciferol, on the other hand, is a vital form of vitamin D3 essential for calcium absorption and bone health. Together, they synergistically combat osteoporosis, making this combination therapy indispensable for maintaining bone integrity.

Formulations:

Each tablet of Alendronate with Cholecalciferol contains Alendronate Sodium equivalent to 70mg of Alendronate and Cholecalciferol 70 mcg (2800 IU). Packaged meticulously in blister packs containing 7 tablets each, our formulation ensures convenience and portability, facilitating adherence to treatment regimens.

Indications:

Our tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women and men at risk of fractures. Additionally, they are invaluable in increasing bone mass in patients with glucocorticoid-induced osteoporosis, addressing a broad spectrum of bone health needs.

Usage:

For optimal efficacy, Alendronate with Cholecalciferol Tablets should be taken orally in the morning on an empty stomach, at least 30 minutes before consuming food, beverages, or other medications. Patients should swallow the tablet whole with a full glass of plain water and maintain an upright position for 30 minutes post-administration to minimize esophageal irritation.

Dosage:

A weekly dosage of one tablet is recommended, with no necessity for dose adjustment based on age, gender, or renal function. Adequate intake of calcium and vitamin D is pivotal during treatment to support bone health and mitigate the risk of hypocalcemia, ensuring comprehensive bone care.

Pharmacokinetics:

Alendronate exhibits poor gastrointestinal absorption, while cholecalciferol undergoes metabolism in the liver to form calcifediol and subsequently calcitriol, the active form of vitamin D. This dual mechanism ensures optimal bone mineralization and calcium absorption, bolstering bone health.

Pharmacodynamics:

By inhibiting osteoclast-mediated bone resorption and promoting calcium absorption and mineralization, our tablets effectively combat bone loss and enhance bone strength, mitigating the risk of fractures and preserving bone integrity.

Side Effects:

While generally well-tolerated, common side effects may include gastrointestinal disturbances such as abdominal pain and nausea. Rare but serious adverse effects such as osteonecrosis of the jaw and atypical femoral fractures necessitate prompt medical attention if experienced.

Experience the comprehensive bone health benefits of Alendronate with Cholecalciferol Tablets from PharmAlliance International Labs. Trust in our unwavering dedication to providing high-quality medications tailored to meet your bone health needs. For more information, please visit our website or consult with your healthcare provider.

Contact Information

• Email: info@Pharmalliance.pk

• Contact Number: 0333-9261419

• WhatsApp: +923018842105